Recursion Pharmaceuticals
clinical is recursion small molecule to reach the clinic selective inhibitor of toxins | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
124 of 143
Similar slides by Recursion Pharmaceuticals
See diffirences between slides (animation)
Investor Day
January 2023
clinical is recursion small molecule to reach the clinic selective inhibitor of toxins | Recursion Pharmaceuticals
Related slides by other companies
Vigil Neuroscience
IPO
January 2022
novel small molecule agonist program vigil | Vigil Neuroscience
Vigil Neuroscience
IPO
January 2022
direct binding of small molecule agonist to vigil | Vigil Neuroscience
Tenaya Therapeutics
IPO
July 2021
i small molecule program | Tenaya Therapeutics
Matinas BioPharma
Investor Presentation
May 2023
beyond small molecules efficient and safe delivery of acids through and external collaborations | Matinas BioPharma
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io